Therapist Joshua Bennett-Johnson gives a critical breakdown of xylazine’s rise in the drug supply, its deadly interaction with fentanyl, and why traditional overdose response is no longer enough. Essential reading for clinicians and communities.

Critics continue to question substance use harm reduction. Advocates persist in fighting for it. But the data is precise: harm reduction saves lives. As patterns of drug use shift and risks increase, strategies such as overdose prevention centers, fentanyl test strips, and naloxone access offer a proven path forward. This isn't theory; it's survival.